DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXV2

Market Closed - Börse Stuttgart 12:02:38 2024-05-31 pm EDT
204.2 EUR +0.85% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-1.75%
1 month-1.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 204.2 +0.85%
24-05-30 202.5 +0.13%
24-05-29 202.3 -0.05%
24-05-28 202.4 -0.46%
24-05-27 203.3 -0.22%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 12:02 pm EDT

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXV
ISINDE000ME7TXV2
Date issued 2024-01-29
Cap 250 $
Last trading day 2024-12-20
Maturity 2024-12-20 (203 Days)
Parity 1 : 1
Emission price 206.6
Emission volume N/A
Payment day 2024-12-31
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 3.732 %
Sideways yield 3.897 %
Sideways yield pa 7.007 %
Outperformance point 259.7 $
Break even 223.27 €
Highest since issue 212.4
Lowest since issue 200.8
Spread 0.08
Spread %0.04%
Distance Cap -18.03 $
Distance Cap %-7.77%
Max. earning 24.64
Max. earning % 11.97 %

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus